# Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

> **NCT00152516** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 255 (actual)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** levetiracetam (LEV)

## Key facts

- **NCT ID:** NCT00152516
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152516, "Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00152516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*